Skip to main content
JAAD International logoLink to JAAD International
. 2023 Sep 23;13:195–197. doi: 10.1016/j.jdin.2023.09.005

Increased IL-1β in stratum corneum as a marker of inflammation among central centrifugal cicatricial alopecia patients with pruritus: An observational study

Aditi Gadre a,b, Taylor Dyson a,c, Jonathan Lai a, Crystal Aguh a,
PMCID: PMC10641221  PMID: 37965352

To the Editor: Central centrifugal cicatricial alopecia (CCCA) is an inflammatory condition of the vertex scalp predominantly affecting Black women. In comparison to cicatricial alopecias like frontal fibrosing alopecia and lichen planopilaris, CCCA often presents without overt signs of disease activity, such as erythema.1 Pruritus has anecdotally been suggested as a sign of disease activity in CCCA patients,1 but this has not been studied. Regular hair washing has been associated with decreased pruritus as well as a reduction in inflammatory markers, interleukin 1 alpha (IL-1α) and its receptor antagonist.2 Through analysis of cytokine expression patterns, our group sought to understand if pruritus is associated with scalp inflammation in CCCA and assess the impact of increased shampoo frequency, a known anti-inflammatory process, on pruritus and inflammation.

In our observational study, we implemented non-invasive tape stripping of the vertex scalp exposed by parting the hair to detect cytokine levels. Twenty-three Black women who met clinical or histologic criteria for diagnosis of CCCA and 26 Black, female controls were recruited. Patients were excluded if they had been treated with systemic or intralesional immunomodulators or antibiotics within 30 days or topical steroids within 7 days. Patients were stratified by frequency of pruritus as well as washing frequency (Table I). Frequent hair washing was defined as occurring at least biweekly and infrequent as occurring less than monthly. Standard protocols were followed for sample extraction, centrifugation, and concentration via Luminex bead-based immunoassays, with subsequent analysis of cytokines (Table II).

Table I.

Characteristics of patient population

Characteristic CCCA, n = 23, n (%) Control, n = 26, n (%) P value
Age, y, mean 46.34 44.62 .5559
Frequent washing, n (%) 14 (61) 12 (46) .371
Clinical erythema, n (%) 3 (13) 0 (0) .057
Scalp pruritus, n (%) 15 (65) 12 (46) .181
CCCA
Control
Frequent washing Infrequent washing Total Frequent washing Infrequent washing Total
Frequent pruritus 11 4 15 4 8 12
Infrequent or absent pruritus 3 5 8 8 6 14
Total 14 9 23 12 14 26

Table indicates the characteristics of patients enrolled in this study including associated signs and symptoms.

Significant (P < .05).

CCCA, Central centrifugal cicatricial alopecia.

Chi-square test comparing hair washing frequency and scalp pruritus in patients with CCCA; P = .094.

Chi-square test comparing hair washing frequency and scalp pruritus in control patients; P = .225.

Table II.

Scalp cytokines assessed and associated results

Cytokine Hair washing frequency
Pruritus
CCCA
Control
CCCA
Control
Frequent washing (SD) Infrequent
washing (SD)
P value Frequent
washing (SD)
Infrequent washing (SD) P value Frequent pruritus (SD) Infrequent or absent pruritus (SD) P value Frequent pruritus (SD) Infrequent or absent pruritus (SD) P value
IL-1α 1852.69 ± 659.01 2564.02 ± 493.22 .3973 1143.46 ± 243.11 3191.9 ± 588.5 .005 2264.49 ± 443.06 1880.82 ± 385.18 .6192 2785.65 ± 723.94 1784.3 ± 349.93 .2309
IL-1RA 156.44 ± 61.79 331.46 ± 168.55 .3523 90.04 ± 29.35 233.43 ± 57.5 .0385 296.16 ± 75.81 91.32 ± 31.08 .0971 211.09 ± 61.15 129.67 ± 41.35 .2832
IL-1β 19.24 ± 7.51 7.51 ± 2.34 .1561 8.46 ± 3.60 8.99 ± 2.17 .8998 20.1 ± 6.93 4.44 ± .94 .0412 8.42 ± 1.98 9.03 ± 3.36 .8761
IL-8 102.38 ± 31.88 118.07 ± 54.24 .8068 54.16 ± 18.94 80.11 ± 33.36 .5064 136.15 ± 40.08 56.73 ± 22.36 .0988 91.61 ± 37.39 48.00 ± 17.74 .3078
IFN-α 23.41 ± 5.08 25.71 ± 3.59 .7155 22.48 ± 4.07 31.71 ± 5.95 .2136 24.94 ± 4.71 23.11 ± 4.20 .775 30.05 ± 7.20 25.23 ± 3.47 .5538

Table indicates which scalp cytokines were detected above threshold, comparing relevant groups and sub-groups. Assays for cytokines IFN-γ, TNF-α, IL-2, IL-4, IL-6, IL-10, IL-12, IL-13, IL-17A were conducted but were not detectable above threshold and consequently not included in analysis.

IFN-α, Interferon alpha; IFN-γ, interferon gamma; IL, interleukin; IL-1α, interleukin 1 alpha; IL-1β, interleukin 1 beta; IL-1RA, interleukin 1 receptor antagonist; SD, standard deviation; TNF-α, tumor necrosis factor alpha.

Significant (P < .05).

While patients with CCCA reported more frequent scalp pruritus compared to controls, the difference was not statistically significant (P = .181). Additionally, shampooing frequency did not affect the frequency of scalp pruritus in patients with CCCA (P = .094) or control patients (P = .225). However, in patients with CCCA, increased scalp pruritus was associated with higher levels of interleukin 1 beta (IL-1β, P = .0412), whereas in controls, scalp pruritus was not associated with increases in any cytokines tested. As expected, based on prior literature data, shampooing frequency in control patients did result in lower levels of both IL-1 receptor antagonist (P = .0385) and IL-1α (P = .005), but this trend was not observed in CCCA patients (P = .3523 and .0902, respectively).

Our study suggests that in CCCA patients, pruritus is associated with active scalp inflammation, specifically IL-1β. IL-1α is expressed constitutively at high levels in epithelial cells.3 Exfoliation of superficial epidermal cells during shampooing is expected to decrease IL-1α levels in healthy scalp, but this result is likely less pronounced in CCCA due to associated epidermal and dermal changes from scarring. In contrast, IL-1β is inducible, requiring cleavage by a protease, caspase-1, which is activated by a nucleotide-binding domain-like receptor protein 3 inflammasome.3 Interestingly, IL-1β has been shown to increase expression of protease activated receptor-2,4 a critical component of the cowhage itch pathway, which also has been implicated in CCCA.5 This study is limited by its sample size but identifies a potential therapeutic target and affirms utility of tracking pruritus in CCCA patients.

Conflicts of interest

None disclosed.

Acknowledgments

We would like to thank Christopher Thoburn, BS of the SKCCC Immune Monitoring Core at The Johns Hopkins University School of Medicine for conducting sample analysis.

Footnotes

Drs Gadre and Dyson contributed equally and are co-first authors.

Funding sources: American Academy of Dermatology H.A.I.R. Award.

Patient consent: Consent for participation in this study was obtained from all patients.

IRB approval status: Reviewed and approved by Johns Hopkins Medicine IRB; approval #NA_00013177.

References

  • 1.Ogunleye T.A., McMichael A., Olsen E.A. Central centrifugal cicatricial alopecia: what has been achieved, current clues for future research. Dermatol Clin. 2014;32(2):173–181. doi: 10.1016/j.det.2013.12.005. [DOI] [PubMed] [Google Scholar]
  • 2.Kobayashi M., Ito K., Sugita T., et al. Physiological and microbiological verification of the benefit of hair washing in patients with skin conditions of the scalp. J Cosmet Dermatol. 2016;15(4):e1–e8. doi: 10.1111/jocd.12228. [DOI] [PubMed] [Google Scholar]
  • 3.Dinarello C.A. Overview of the IL-1 family in innate inflammation and acquired immunity. Immunol Rev. 2018;281(1):8–27. doi: 10.1111/imr.12621. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Kim D.H., Lee B., Lee J., et al. FoxO6-mediated IL-1β induces hepatic insulin resistance and age-related inflammation via the TF/PAR2 pathway in aging and diabetic mice. Redox Biol. 2019;24 doi: 10.1016/j.redox.2019.101184. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Bin Saif G.A., McMichael A., Kwatra S.G., Chan Y.H., Yosipovitch G. Central centrifugal cicatricial alopecia severity is associated with cowhage-induced itch. Br J Dermatol. 2013;168(2):253–256. doi: 10.1111/bjd.12043. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from JAAD International are provided here courtesy of Elsevier

RESOURCES